Triprolidine
Triprolidine is an antihistamine medication belonging to the first-generation H1 receptor antagonist class. It is commonly used to relieve symptoms of allergic conditions such as allergic rhinitis, sneezing, runny nose, watery eyes, and itching. It works by blocking histamine H1 receptors, thereby reducing allergic reactions in the body. It helps provide relief from symptoms associated with the common cold and other respiratory allergies. Triprolidine is usually administered orally in tablet or liquid form and is often combined with decongestants such as pseudoephedrine. Common side effects include drowsiness, dizziness, dry mouth, blurred vision, and constipation. It may also cause impaired alertness and coordination. It should be used cautiously under medical supervision.
Triprolidine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Triprolidine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Triprolidine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Triprolidine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
